Zometa and Red cell distribution width increased - a phase IV clinical study of FDA data
We study 69,847 people who have side effects when taking Zometa. Red cell distribution width increased is found, especially among people who are female, 60+ old, have been taking the drug for 2 - 5 years, also take Coumadin and have Metastases to bone.
The phase IV clinical study analyzes which people take Zometa and have Red cell distribution width increased. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
69,847 people reported to have side effects when taking Zometa.
Among them, 303 people (0.43%) have Red cell distribution width increased.
What is Zometa?
Zometa has active ingredients of zoledronic acid. It is used in multiple myeloma. Currently, eHealthMe is studying from 70,204 Zometa users.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 1,069 drugs and 599 conditions by eHealthMe. Currently, we are studying 5,064 people who have Red cell distribution width increased.
Number of Zometa and Red cell distribution width increased reports submitted per year:
Time on Zometa when people have Red cell distribution width increased *:
Gender of people who have Red cell distribution width increased when taking Zometa*:
Age of people who have Red cell distribution width increased when taking Zometa *:
Common drugs people take besides Zometa *:
Common side effects people have besides Red cell distribution width increased *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zometa and have Red cell distribution width increased?Check whether Red cell distribution width increased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Zometa side effects by duration, gender and age:
- Zometa side effects (70,204 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,064 reports)
Common drugs associated with Red cell distribution width increased:
- Prednisone: 750 reports
- Methotrexate: 495 reports
- Aspirin: 373 reports
- Tylenol: 347 reports
- Benadryl: 314 reports
- Zometa: 303 reports
- Pantoprazole: 297 reports
- Metformin: 271 reports
- Hydramine: 230 reports
- Synthroid: 230 reports
All the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (1,069 drugs)
Common conditions associated with Red cell distribution width increased:
- Relapsing-remitting multiple sclerosis: 276 reports
- Rheumatoid arthritis: 270 reports
- Multiple sclerosis: 226 reports
- Pain: 212 reports
- Breast cancer: 209 reports
- High blood pressure: 187 reports
- Schizophrenia: 182 reports
- Asthma: 160 reports
All the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (599 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on zoledronic acid (the active ingredients of Zometa) and Zometa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Xarelto and Postoperative Wound Complication - 8 seconds ago
- Nifedipine and Octocaine drug interaction - 11 seconds ago
- Cozaar and Crohn'S Disease - 13 seconds ago
- Humalog and Naprosyn drug interaction - 16 seconds ago
- Myrbetriq and Golytely drug interaction - 20 seconds ago
- Velcade and Pneumonia - 29 seconds ago
- Ibu and Burkitt Lymphoma - 29 seconds ago
- Lansoprazole and Plaquenil drug interaction - 33 seconds ago
- Mucinex Dm and Mirena drug interaction - 35 seconds ago
- Lamivudine and Protein Urine Present - 38 seconds ago